drugset

drugset / Trial / NCT04453488

Clinical Trial to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers

NCT04453488 ↗

Phase 3 Unknown 315 enrolled Germans Trias i Pujol Research Institute

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to assess the efficacy of RUTI® vaccine preventing SARS-CoV-2 infection (COVID-19) in healthcare workers.

Timeline

Start: 2020-07-30
Primary completion: 2020-12
Completion: 2020-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	RUTI®	Vaccine	25 ug	Subcutaneous

Indications